Cancer Vaccine Galinpepimut-S Prolongs Life of Patients with AML, Results of Pilot Trial Show
News
Second-line maintenance therapy with the experimental vaccine galinpepimut-S (GPS) significantly prolongs the life of patients with acute myeloid leukemia (AML) who are on their second remission of the disease, according ... Read more